Skip to Content

Join the 'Juvenile Idiopathic Arthritis' group to help and get support from people like you.

Juvenile Idiopathic Arthritis News

FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira

Posted 30 Aug 2017 by Drugs.com

Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases, including: moderate to severe active rheumatoid arthritis moderate to severe polyarticular juvenile idiopathic arthritis** active psoriatic arthritis active ankylosing spondylitis (an arthritis that affects the spine) moderate to severe active adult Crohn’s disease moderate to severe active ulcerative colitis moderate to severe plaque psoriasis “Cyltezo is the first biosimilar from Boehringer Ingelheim to be approved by the FDA and marks an important step towards our goal of providing new and more affordable treatment options to healthcare providers and patients,” said Ivan Blanarik, Senior Vice President and Head of The ... Read more

Related support groups: Rheumatoid Arthritis, Humira, Psoriasis, Crohn's Disease, Psoriatic Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Crohn's Disease - Maintenance, Plaque Psoriasis, Ulcerative Colitis - Active, Crohn's Disease - Acute, Juvenile Rheumatoid Arthritis, Ulcerative Colitis - Maintenance, Juvenile Idiopathic Arthritis, Humira Pen, Adalimumab, Amjevita, Cyltezo

Certain Jobs Linked to Raised Risk of Rheumatoid Arthritis

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Rheumatoid arthritis, a painful disease in which a person's immune system attacks the joints, appears to be more common among people in certain types of jobs, researchers suggest. The findings "indicate that work-related factors, such as airborne harmful exposures, may contribute to disease development," study author Anna Ilar said. She is a doctoral student in epidemiology at the Karolinska Institute in Stockholm. The study looked at more than 3,500 people in Sweden with rheumatoid arthritis, and nearly 5,600 people without the disease. Among men, those in manufacturing jobs had a higher risk of rheumatoid arthritis than those in the professional, administrative and technical sectors, the findings showed. The risk was twice as high for electrical and electronics workers, and three times higher for bricklayers and concrete workers. Among women, assistant ... Read more

Related support groups: Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Still's Disease, Rheumatoid Lung, Felty's Syndrome

Fish Eaters Report Less Rheumatoid Arthritis Pain

Posted 23 Jun 2017 by Drugs.com

FRIDAY, June 23, 2017 – Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis, a new study says. Prior studies have shown a beneficial effect of fish oil supplements on rheumatoid arthritis symptoms, but less is known about the value of eating fish containing omega-3, the researchers said. "We wanted to investigate whether eating fish as a whole food would have a similar kind of effect as the omega 3 fatty acid supplements," said the study author, Dr. Sara Tedeschi, an associate physician of rheumatology, immunology and allergy at Brigham and Women's Hospital in Boston. Generally, the amount of omega 3 fatty acids in fish is lower than the doses that were given in the trials, she said. Even so, as the 176 study participants increased the amount of fish they ate weekly, their disease activity score lowered, the ... Read more

Related support groups: Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Still's Disease, Rheumatoid Lung, Felty's Syndrome

FDA Approves Xatmep (methotrexate) Oral Solution

Posted 27 Apr 2017 by Drugs.com

Denver, April 26, 2017 — Silvergate Pharmaceuticals, Inc. leaders in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration (FDA) approved Xatmep (methotrexate) Oral Solution, the first and only FDA-approved methotrexate oral solution. Xatmep is indicated for the treatment of acute lymphoblastic leukemia (ALL) and polyarticular juvenile idiopathic arthritis (pJIA) in pediatric patients. “Xatmep is an exciting product in that it provides an FDA-approved, ready-to-use oral solution of methotrexate for children without the need for needles, crushing of tablets or compounding into a liquid formulation,” said Frank Segrave, President & CEO, Silvergate Pharmaceuticals, Inc. “As a company, we continue to focus on pediatric medications that are safe, effective, and readily available.” Xatmep (meth ... Read more

Related support groups: Methotrexate, Leukemia, Acute Lymphoblastic Leukemia, Juvenile Idiopathic Arthritis, Xatmep

Early Treatment Equals Better Results for Rheumatoid Arthritis

Posted 25 Apr 2017 by Drugs.com

TUESDAY, April 25, 2017 – Treating rheumatoid arthritis early may make for better outcomes, a new study suggests. Patients who were treated within six months of developing the first signs of the autoimmune disease did better in the long run and were less likely to suffer early death, British researchers found. The findings stem from an analysis of more than 600 patients who were initially diagnosed with rheumatoid arthritis (RA) between 1990 and 1994. They were tracked for over 20 years. Over the study time frame, investigators assessed key symptoms of RA, such as swollen and/or tender joints, and indications of disability. All deaths were also noted. The research team found that patients who started treatment for RA within the first half-year after the first symptoms surfaced tended to have no greater levels of disability over a 20-year period than patients who required no treatment. ... Read more

Related support groups: Rheumatoid Arthritis, Methotrexate, Humira, Enbrel, Remicade, Plaquenil, Hydroxychloroquine, Rituxan, Otezla, Sulfasalazine, Imuran, Orencia, Rituximab, Leflunomide, Arava, Azathioprine, Juvenile Rheumatoid Arthritis, Xeljanz, Infliximab, Juvenile Idiopathic Arthritis

1 in 4 U.S. Adults Disabled by Arthritis: CDC

Posted 8 Mar 2017 by Drugs.com

TUESDAY, March 7, 2017 – Arthritis is expanding its grip on Americans, with 24 million adults limited in their everyday activities because of the debilitating joint disease, U.S. health officials say. Overall, 54 million adults – or one in four – report an arthritis diagnosis. And the number of people disabled by it has jumped 20 percent since 2002, the U.S. Centers for Disease Control and Prevention reported Tuesday. "Arthritis symptoms keep millions of Americans from going about their daily routines," CDC acting director Dr. Anne Schuchat said in an agency news release. The joint aches, stiffness and swelling of arthritis can make holding a glass, carrying a grocery bag, or walking a short distance difficult or even impossible, the agency said. Why so many Americans have arthritis isn't clear, and can't be attributed solely to an aging population. Almost two of five adults with ... Read more

Related support groups: Suboxone, Oxycodone, Obesity, Diabetes, Type 2, Hydrocodone, Tramadol, Percocet, Methadone, Rheumatoid Arthritis, OxyContin, Vicodin, Norco, Fentanyl, Osteoarthritis, Morphine, Codeine, Lortab, Opana, Subutex, Heart Disease

Even a Little Exercise Can Help With Arthritis, Study Says

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – Just a little physical activity seems to go a long way toward helping older adults with arthritis remain able to do daily tasks, a new study finds. Older adults with arthritis-related joint pain and stiffness need to keep moving to remain functionally independent. But only 10 percent of older Americans with arthritis in their knees meet federal guidelines of at least 150 minutes of moderate activity a week, the researchers said. However, this Northwestern University study found that doing even about one-third of that amount is still beneficial. The study involved more than 1,600 adults 49 or older who had arthritic pain or stiffness in their hips, knees or feet. Those who did a minimum of 45 minutes of moderate activity – such as brisk walking – a week were 80 percent more likely to improve or sustain physical function and gait speed over two years, compared ... Read more

Related support groups: Pain, Back Pain, Rheumatoid Arthritis, Osteoarthritis, Chronic Pain, Ibuprofen, Naproxen, Meloxicam, Advil, Diclofenac, Voltaren, Neck Pain, Aleve, Mobic, Motrin, Hip Replacement, Indomethacin, Toradol, Etodolac, Nabumetone

Health Tip: What's Behind My Foot Arthritis?

Posted 21 Dec 2016 by Drugs.com

-- The stiffness and pain that accompany arthritis are particularly noticable when they affect the feet. Here are possible reasons behind foot arthritis, courtesy of the American Podiatric Medical Association: Foot injuries, particularly if they were not treated properly. Viral or bacterial infections that affect the joints. Inflammatory bowel disease. Prescribed medications or use of illegal drugs. An autoimmune disease. Read more

Related support groups: Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Foot Care, Felty's Syndrome

Health Tip: Exercising With Arthritis

Posted 1 Dec 2016 by Drugs.com

-- Exercise usually is good for those with arthritis, but there are many potential obstacles to keep you inactive. Here are strategies to keep you moving, courtesy of the Arthritis Foundation: No time? Exercise in short bursts, even just 10 minutes at a time. Find a fitness partner to help keep it fun. If you're having pain, try a low-impact exercise, such as swimming. Exercise even when you're tired, as regular exercise helps boost energy. Don't look at exercise as just a way to lose weight. It also helps manage pain, increase flexibility and makes it easier to do daily tasks. Look for a new gym if you feel self-conscious at the current one. If money is a concern, just go for a walk or buy inexpensive home workout equipment. Try interval training, a few minutes of vigorous exercise followed by a recovery period, if you're not seeing changes. Visit a personal trainer. Schedule workouts ... Read more

Related support groups: Rheumatoid Arthritis, Osteoarthritis, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Still's Disease, Rheumatoid Lung

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids

Posted 16 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 16, 2016 – Some children born to mothers with rheumatoid arthritis may have higher-than-average odds of developing epilepsy, a new study suggests. Children born to mothers with rheumatoid arthritis were one-third more likely to develop epilepsy by age 4 than other children. The risk of epilepsy later in childhood was one-quarter higher for those born to moms with rheumatoid arthritis, the study found. But, experts stressed that the findings don't prove that a mother's rheumatoid arthritis causes epilepsy. So far, only an association has been found. And even if children of women with rheumatoid arthritis have a higher epilepsy risk than other kids do, the odds are still low. In the study of nearly 2 million children, the vast majority of those born to moms with rheumatoid arthritis did not develop epilepsy, said lead researcher Ane Lilleore Rom, of Copenhagen University ... Read more

Related support groups: Rheumatoid Arthritis, Seizures, Epilepsy, Seizure Prevention, Juvenile Rheumatoid Arthritis, Seizure Prophylaxis, Juvenile Idiopathic Arthritis, Still's Disease, Diagnosis and Investigation, Rheumatoid Lung, Felty's Syndrome

Having Rheumatoid Arthritis May Increase Heart Risk

Posted 15 Nov 2016 by Drugs.com

TUESDAY, Nov. 15, 2016 – People with rheumatoid arthritis may have an increased risk for a heart attack, stroke and other heart disease-related problems, a new study suggests. Researchers examined data from 353 rheumatoid arthritis patients in the Netherlands who were followed for up to 15 years. The rate of heart disease-related events in these patients was more than twice that of the general population, the findings showed. The rate among rheumatoid arthritis patients was similar to that of people with type 2 diabetes. The risk among rheumatoid arthritis patients remained as much as 70 percent higher than the general population even after the researchers adjusted for known heart disease risk factors, according to the report authors. But, the study didn't prove a cause-and-effect relationship. The research was only designed to show that rheumatoid arthritis was associated with heart ... Read more

Related support groups: Rheumatoid Arthritis, Ischemic Stroke, Heart Attack, Transient Ischemic Attack, Myocardial Infarction, Juvenile Rheumatoid Arthritis, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Juvenile Idiopathic Arthritis, Still's Disease, Myocardial Infarction - Prophylaxis, Felty's Syndrome

Amjevita OK'd to Treat Inflammatory Diseases

Posted 27 Sep 2016 by Drugs.com

MONDAY, Sept. 26, 2016 – Amjevita (adalimumab-atto) – a biosimilar drug similar to the popular anti-inflammatory drug Humira – has been approved by the U.S. Food and Drug Administration. Amjevita has been approved for moderate-to-severe rheumatoid arthritis; psoriatic arthritis; ankylosing spondylitis (an arthritis that affects the spine); Crohn's disease; ulcerative colitis; plaque psoriasis and juvenile idiopathic arthritis, the FDA said in a news release. Biological drugs are generally derived from a living organism and can come from many sources, including humans, animals, microorganisms or yeast, the FDA said. A biosimilar drug is a biological product that's sanctioned after its maker proves it is "highly similar" to an already-approved biologic drug. The manufacturer of the biosimilar drug must prove that the product has "no clinically meaningful differences" in safety, purity ... Read more

Related support groups: Rheumatoid Arthritis, Humira, Crohn's Disease, Psoriatic Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Crohn's Disease - Maintenance, Plaque Psoriasis, Ulcerative Colitis - Active, Crohn's Disease - Acute, Ulcerative Colitis - Maintenance, Juvenile Idiopathic Arthritis, Adalimumab, Amjevita

Health Tip: Traveling With Arthritis

Posted 9 Sep 2016 by Drugs.com

-- Arthritis doesn't have to ruin your vacation. Here are relief suggestions from the Arthritis Foundation: Book a plane seat with extra room to stretch. Fly in the middle of the week when it's less busy. Ask for a hotel room that's on the first floor or near an elevator. Pack a cane or an extra pillow to help you stay comfortable. Pack a stash of healthier snacks. Pack medications in your carry-on baggage. Make sure meds are packed properly, especially if they need refrigeration. Pack a heating pad or wrap, an ice pack and topical creams. Opt for a hotel with a hot tub or steam room. Request assistance at the airport to prevent long walks or long periods standing. Ask another passenger for help storing carry-on luggage. Move around the plane's cabin as frequently as possible. Read more

Related support groups: Rheumatoid Arthritis, Osteoarthritis, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Still's Disease, Rheumatoid Lung, Felty's Syndrome

FDA Approves Erelzi (etanercept-szzs), a Biosimilar to Enbrel

Posted 1 Sep 2016 by Drugs.com

August 30, 2016 – The U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. Erelzi is administered by injection for the treatment of: moderate to severe rheumatoid arthritis, either as a standalone therapy or in combination with methotrexate (MTX); moderate to severe polyarticular juvenile idiopathic arthritis in patients ages two and older; active psoriatic arthritis, including use in combination with MTX in psoriatic arthritis patients who do not respond adequately to MTX alone; active ankylosing spondylitis (an arthritis that affects the spine); and chronic moderate to severe plaque psoriasis in adult patients (18 years or older) who are candidates for systemic therapy or phototherapy. Health care professionals should review the prescribing ... Read more

Related support groups: Rheumatoid Arthritis, Enbrel, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Juvenile Idiopathic Arthritis, Etanercept, Erelzi

FDA Approves New Biological Drug for Rheumatoid Arthritis

Posted 31 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 31, 2016 – A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration. The drug Erelzi (etanercept-szzs) is a "biosimilar" to Enbrel (etanercept), which was approved by the FDA in 1998. A biosimilar is a biological product approved on findings that it is highly similar to an already-approved biological product and has no clinically meaningful differences in terms of safety and effectiveness, according to the FDA. It is similar to generic drugs in that it typically costs less than the original biological product. Biological products are typically derived from a living organism and include many sources, including humans, animals, microorganisms or yeast. "The biosimilar pathway is an important mechanism to improve access to treatment for patients with rheumatic and autoimmune diseases," ... Read more

Related support groups: Rheumatoid Arthritis, Enbrel, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Still's Disease, Etanercept, Erelzi, Rheumatoid Lung, Felty's Syndrome

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Juvenile Rheumatoid Arthritis

Related Drug Support Groups

methotrexate, Humira, Enbrel, Orencia, Actemra, infliximab, adalimumab, etanercept, Ilaris, view more... Amjevita, Erelzi, abatacept, tocilizumab, Cyltezo, Otrexup, Rasuvo, canakinumab, Xatmep